XTRACT ONE TECHNOLOGIES INC (XTRA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:XTRA - CA98422Q1063 - Common Stock
0.65 CAD
+0.02 (+3.17%)
Taking everything into account, XTRA scores 3 out of 10 in our fundamental rating. XTRA was compared to 11 industry peers in the Aerospace & Defense industry. XTRA may be in some trouble as it scores bad on both profitability and health. XTRA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year XTRA has reported negative net income.
In the past year XTRA has reported a negative cash flow from operations.
XTRA had negative earnings in each of the past 5 years.
In the past 5 years XTRA always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -50.73%, XTRA is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
XTRA's Return On Equity of -111.15% is fine compared to the rest of the industry. XTRA outperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.73% | ||
| ROE | -111.15% | ||
| ROIC | N/A |
ROA(3y)-60.36%
ROA(5y)-86.91%
ROE(3y)-100.39%
ROE(5y)-121.9%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of XTRA (65.54%) is better than 100.00% of its industry peers.
The Profit Margin and Operating Margin are not available for XTRA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.54% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
XTRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XTRA has more shares outstanding
The number of shares outstanding for XTRA has been increased compared to 5 years ago.
The debt/assets ratio for XTRA is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -3.12, we must say that XTRA is in the distress zone and has some risk of bankruptcy.
XTRA's Altman-Z score of -3.12 is on the low side compared to the rest of the industry. XTRA is outperformed by 72.73% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that XTRA is not too dependend on debt financing.
The Debt to Equity ratio of XTRA (0.08) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.12 |
ROIC/WACCN/A
WACC8.77%
2.3 Liquidity
A Current Ratio of 1.64 indicates that XTRA should not have too much problems paying its short term obligations.
The Current ratio of XTRA (1.64) is better than 81.82% of its industry peers.
XTRA has a Quick Ratio of 1.34. This is a normal value and indicates that XTRA is financially healthy and should not expect problems in meeting its short term obligations.
XTRA has a better Quick ratio (1.34) than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.34 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 1.65% over the past year.
XTRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.31%.
The Revenue has been growing by 46.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-15.31%
Revenue growth 3Y56.42%
Revenue growth 5Y46.26%
Sales Q2Q%-40.63%
3.2 Future
The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
XTRA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 62.98% yearly.
EPS Next Y49%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.71%
Revenue Next 2Y62.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for XTRA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XTRA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
XTRA's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for XTRA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:XTRA (11/21/2025, 7:00:00 PM)
0.65
+0.02 (+3.17%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners0.41%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap155.43M
Revenue(TTM)13.85M
Net Income(TTM)-11.88M
Analysts82.5
Price Target1.1 (69.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-47.06%
Min EPS beat(2)-96.08%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)-10.29%
Min EPS beat(4)-96.08%
Max EPS beat(4)50.98%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-30.28%
Min Revenue beat(2)-34.03%
Max Revenue beat(2)-26.53%
Revenue beat(4)0
Avg Revenue beat(4)-25.48%
Min Revenue beat(4)-38.64%
Max Revenue beat(4)-2.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-66.67%
EPS NY rev (3m)-66.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.08%
Revenue NY rev (3m)-10.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 11.22 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 14.55 | ||
| P/tB | 25.24 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.06
BVpS0.04
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -50.73% | ||
| ROE | -111.15% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.54% | ||
| FCFM | N/A |
ROA(3y)-60.36%
ROA(5y)-86.91%
ROE(3y)-100.39%
ROE(5y)-121.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.34% | ||
| Cap/Sales | 6.64% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.34 | ||
| Altman-Z | -3.12 |
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)20.53%
Cap/Depr(5y)19.86%
Cap/Sales(3y)3.35%
Cap/Sales(5y)13.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y49%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.31%
Revenue growth 3Y56.42%
Revenue growth 5Y46.26%
Sales Q2Q%-40.63%
Revenue Next Year79.71%
Revenue Next 2Y62.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year108.16%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.69%
OCF growth 3YN/A
OCF growth 5YN/A
XTRACT ONE TECHNOLOGIES INC / XTRA.CA FAQ
What is the fundamental rating for XTRA stock?
ChartMill assigns a fundamental rating of 3 / 10 to XTRA.CA.
What is the valuation status for XTRA stock?
ChartMill assigns a valuation rating of 1 / 10 to XTRACT ONE TECHNOLOGIES INC (XTRA.CA). This can be considered as Overvalued.
How profitable is XTRACT ONE TECHNOLOGIES INC (XTRA.CA) stock?
XTRACT ONE TECHNOLOGIES INC (XTRA.CA) has a profitability rating of 1 / 10.
What is the financial health of XTRACT ONE TECHNOLOGIES INC (XTRA.CA) stock?
The financial health rating of XTRACT ONE TECHNOLOGIES INC (XTRA.CA) is 3 / 10.